Heart Disease News and Research

Latest Heart Disease News and Research

First human implant of St. Jude Medical's Portico transcatheter aortic heart valve

St. Jude Medical, Inc., a global medical device company, today announced the first human implant of its Portico transcatheter aortic heart valve. The procedure was performed by Dr. John Webb, director of cardiac catheterization and interventional cardiology at St. Paul's Hospital in Vancouver, British Columbia.

7 Jun 2011

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

Cyterix Pharmaceutics, Inc. announced today that the company has raised $9.2 million in a Series A financing from The Column Group and SV Life Sciences. Cyterix is developing novel cancer therapeutics based on a prodrug approach that targets extra-hepatic cytochrome P450 enzymes that are over-expressed in many cancers to a high frequency, but not in normal tissues.

7 Jun 2011

Smoking increases woman's risk for peripheral artery disease 10-fold

A prospective study of initially healthy women aged 45 and over found that smoking is a potent risk factor for symptomatic peripheral artery disease, or PAD. PAD is a serious, often debilitating disorder, caused by narrowing of the arteries in the lower extremities. Symptoms of PAD include pain in the legs with normal activity and a feeling of tiredness in the leg muscles.

7 Jun 2011

LUMEDX releases new Webinar, The Power of Analytics: Managing Cath Lab Growth in Real Time

LUMEDX Corporation, a leading provider of integrated cardiovascular information systems (CVIS), today announced the release of a new and complimentary educational Webinar on CD, The Power of Analytics: Managing Cath Lab Growth in Real Time.

7 Jun 2011

Key heart failure therapies could prevent nearly 68,000 deaths each year

A national study has found that nearly 68,000 deaths potentially could be prevented each year by optimally implementing key national guideline-recommended therapies, including critical medications and cardiac devices, for all eligible heart failure patients.

7 Jun 2011

LWW sponsors 26th Annual Clinical Symposium on Advances in Skin & Wound Care

The 26th Annual Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing will be held September 9-12, 2011, at the Gaylord National Hotel & Convention Center, National Harbor, MD.

7 Jun 2011

Proteus, Avery Dennison partner for patch-based wearable sensors

Avery Dennison Medical Solutions, a division of Avery Dennison Corporation and a global leader in pressure-sensitive adhesive technologies for medical applications, in cooperation with Proteus Biomedical, Inc., a leader in intelligent medicine and mobile health products, today announced a partnership focusing on patch-based wearable sensors for consumer, home health care and remote medical applications.

7 Jun 2011

Novel technique promises to reduce damage after heart attack

Scientists at the University of Leicester are investigating a novel technique that promises to protect heart muscle from life-threatening damage following a heart attack - simply by squeezing an arm. Heart attacks are the major cause of premature death in England, with massive implications for survival and costs of long-term health care.

7 Jun 2011

Tβ4 activates Akt survival kinase and reduces heart attack damage

RegeneRx Biopharmaceuticals, Inc. has announced that researchers have shown that Tβ4 has more extensive beneficial effects on the myocardium after heart attack than previously reported.

7 Jun 2011

ABRAXANE and bevacizumab clinical studies on unresectable melanoma presented at ASCO 2011

Celgene International Sàrl today announced that results from two investigator initiated studies including ABRAXANE, and bevacizumab in unresectable melanoma were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, IL.

7 Jun 2011

Celgene announces ABRAXANE plus gemcitabine, bevacizumab phase II trial data on breast cancer

Celgene International Sàrl today announced that results from an investigator-initiated phase II study of ABRAXANE, gemcitabine and bevacizumab as first-line treatment in metastatic breast cancer were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, IL.

7 Jun 2011

The Endocrine Society releases clinical practice guideline on Vitamin D deficiency

Today, The Endocrine Society released "Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline." The clinical practice guideline (CPG) is published in the July 2011 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.

7 Jun 2011

Race impacts risk of heart disease after gestational diabetes

New research finds that gestational diabetes, or pregnancy-related diabetes, may not raise the risk of heart disease independent of other cardiovascular risk factors except in certain high-risk populations, such as Hispanics. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.

7 Jun 2011

Ovarian cancer screenings do not reduce risk of death

A University of Alabama at Birmingham study released today reports that ovarian cancer screenings do not reduce a woman's risk of death from the disease and the invasive medical procedures may create associated health problems.

7 Jun 2011

New laboratory method uses SALL4 gene to expand adult hematopoietic stem cells

Researchers in the Department of Pathology at Stony Brook University School of Medicine have discovered a laboratory method to expand adult hematopoietic stem cells (HSCs) using the SALL4 gene. Professor Yupo Ma, M.D., Ph.D., Lead Author, and colleagues used this method to produce a more than 10,000-fold increase in HSCs derived from normal human bone marrow.

7 Jun 2011

Non-steroidal, oral contraceptive for men

Researchers at Columbia University Medical Center are honing in on the development of what may be the first non-steroidal, oral contraceptive for men. Tests of low doses of a compound that interferes with retinoic acid receptors (RARs), whose ligands are metabolites of dietary vitamin A, showed that it caused sterility in male mice.

7 Jun 2011

Frog skin proteins could treat cancer, diabetes and stroke: New discovery

Scientists at Queen's University Belfast have discovered proteins in frog skins which could be used to treat cancer, diabetes, stroke and transplant patients by regulating the growth of blood vessels.

7 Jun 2011

Gleevec shows significant overall survival benefit for patients w/ GIST after 3 years of adjuvant treatment vs. 1 year

Novartis announced new data today showing a significant improvement in both recurrence-free survival and overall survival for patients taking Gleevec® (imatinib mesylate)* tablets for three years after surgery to remove KIT (CD117)-positive gastrointestinal stromal tumors (KIT+ GIST) compared to one year of treatment. These data will be presented at the 47th American Society of Clinical Oncology (ASCO) plenary session on Sunday, June 5.

6 Jun 2011

Merge Healthcare, Ophthalmic Imaging Systems enter definitive merger agreement

Merge Healthcare, a leading provider of healthcare enterprise imaging and interoperability solutions, and Ophthalmic Imaging Systems, a leading provider of digital imaging and informatics solutions for ophthalmology and other medical specialties, today announced the signing of a definitive merger agreement pursuant to which Merge Healthcare will acquire OIS.

6 Jun 2011

Ganeden Biotech sells Sustenex and Digestive Advantage to Schiff for $40 million

Ganeden Biotech announced the sale of its leading Sustenex® and Digestive Advantage® brands of probiotic dietary supplements to Schiff Nutrition International, Inc. for $40 million in cash. Ganeden will also receive royalties on Schiff products containing GanedenBC30™.

6 Jun 2011

Heart Disease News and Research

Latest Heart Disease News and Research

First human implant of St. Jude Medical's Portico transcatheter aortic heart valve

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

Smoking increases woman's risk for peripheral artery disease 10-fold

LUMEDX releases new Webinar, The Power of Analytics: Managing Cath Lab Growth in Real Time

Key heart failure therapies could prevent nearly 68,000 deaths each year

LWW sponsors 26th Annual Clinical Symposium on Advances in Skin & Wound Care

Proteus, Avery Dennison partner for patch-based wearable sensors

Novel technique promises to reduce damage after heart attack

Tβ4 activates Akt survival kinase and reduces heart attack damage

ABRAXANE and bevacizumab clinical studies on unresectable melanoma presented at ASCO 2011

Celgene announces ABRAXANE plus gemcitabine, bevacizumab phase II trial data on breast cancer

The Endocrine Society releases clinical practice guideline on Vitamin D deficiency

Race impacts risk of heart disease after gestational diabetes

Ovarian cancer screenings do not reduce risk of death

New laboratory method uses SALL4 gene to expand adult hematopoietic stem cells

Non-steroidal, oral contraceptive for men

Frog skin proteins could treat cancer, diabetes and stroke: New discovery

Gleevec shows significant overall survival benefit for patients w/ GIST after 3 years of adjuvant treatment vs. 1 year

Merge Healthcare, Ophthalmic Imaging Systems enter definitive merger agreement

Ganeden Biotech sells Sustenex and Digestive Advantage to Schiff for $40 million

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in